Comparing the Diagnostic Accuracy of Clinical Dehydration Scales Among Small Children
NCT ID: NCT02249845
Last Updated: 2016-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
108 participants
OBSERVATIONAL
2014-09-30
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DESHYDRAT : Assessment of the Prevalence of Dehydration Among 9 to 11 Year-old Children
NCT01268826
DeHydration: Assessing Kids Accurately
NCT02007733
Newborn Screening for Congenital Heart Disease
NCT01665261
Assessment of CAI in Adults With PWS.
NCT04700644
Measurement of Lung Area at Chest Radiography to Define the Prognosis in Newborns With CDH
NCT04396028
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The next body mass evaluation will take place, when patient's clinical condition will by classified as good by the attending physician and the child will be at least 24 hours after finishing intravenous or probe rehydration therapy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dehydration scales
children aged 1 - 36 months for CDS scale; 1 month - 5 years old for WHO scale and Gorelick scale
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hospitalisation caused by acute diarrhea (acute diarrhea -increase in the frequency of evacuations ≥ 3 in 24 hours; with or without fever or vomiting)
* duration of symptoms under 5 days
* parents' written consent for child's participation in the study
Exclusion Criteria
* acidosis
* kidney failure
* heart failure
* chronic liver disease
* respiratory failure
* condition after surgery
1 Month
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Warsaw
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Piotr Dziechciarz, MD
Medical Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anna Falszewska, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Warsaw
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Pediatrics, Medical University of Warsaw
Warsaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.